Filing status
- Accounts due
- 28 February 2027
- Last accounts
- 31 May 2025
- Conf. stmt due
- 11 August 2027
- Last conf. stmt
- 28 July 2026
Akro Pharmaceutical Company Limited
- Incorporated
- 28 September 1998 (28 years)
- Industry
- Wholesale of pharmaceutical goods (46460)
- Directors
- Felicia Gloria AdjeiSamuel Tetteh Adjei
- Owned by
- Karl Mawunyega Olesu AdjeiFelicia Gloria AdjeiSamuel Tetteh Adjei
- Accounts type
- Total exemption full
- Region
- Greater London
- Address
- Abacus House68A North StreetRomfordRM1 1DA
Charges
- Total
- 1
- Outstanding
- 1
- Part satisfied
- 0
- Satisfied
- 0
Officers 4 active
Officer details are public data from the Companies House register.
British
Born August 1985 (41)
Adjei, Felicia Gloria
Secretary · Appointed 28 September 1998
British
Adjei, Felicia Gloria
Director · Appointed 28 September 1998
British
Born August 1956 (70)
Adjei, Samuel Tetteh
Director · Appointed 28 September 1998
British
Born April 1948 (78)
Officer history (2 former)
1 June 2012
28 September 1998
Appointed Adjei, Felicia Gloria as Secretary
28 September 1998
Appointed Adjei, Felicia Gloria as Director
28 September 1998
Appointed Adjei, Samuel Tetteh as Director
28 September 1998
28 September 1998
28 September 1998
28 September 1998
Ownership 3 active
People and entities with significant control, from the Companies House PSC register
Individual · Notified 1 March 2017
Owns 25–50% of shares
Holds 25–50% of voting rights
British
Born August 1985 (41)
Felicia Gloria Adjei
Individual · Notified 1 March 2017
Owns 25–50% of shares
Holds 25–50% of voting rights
British
Born August 1956 (70)
Samuel Tetteh Adjei
Individual · Notified 1 March 2017
Owns 25–50% of shares
Holds 25–50% of voting rights
British
Born April 1948 (78)
Former controllers (4)
30 January 2024
Ceased Felicia Gloria Adjei — Owns 25–50% of shares
30 January 2024
Ceased Samuel Tetteh Adjei — Owns 25–50% of shares
1 March 2017
Ceased Samuel Tetteh Adjei — Owns 25–50% of shares
1 March 2017
Ceased Felicia Gloria Adjei — Owns 25–50% of shares
Financials
Balance sheet as at 31 May 2025 · total exemption full accounts
- Net Assets
- £399,219
- Cash
- £145,959
- Employees
- 6
- Debt Ratio
- 75%
- Current Ratio
- 1.0x
Trend
Net Assets
Balance sheet detail
| 2025 | 2024 | 2023 | 2021 | 2020 | |
|---|---|---|---|---|---|
| Fixed Assets | £728,270 | £742,214 | £431,384 | £434,531 | £435,013 |
| Current Assets | £859,722 | £649,410 | £1,245,584 | £927,060 | £707,238 |
| Debtors | £557,229 | £343,810 | £741,754 | £599,953 | £548,595 |
| Cash | £145,959 | £172,174 | £341,048 | £273,907 | £94,843 |
| Creditors (< 1 year) | £900,338 | £677,720 | £938,536 | £756,911 | £590,275 |
| Creditors (> 1 year) | £283,711 | £344,847 | £406,260 | £333,933 | £359,174 |
| Net Current Assets | (£40,616) | (£28,310) | £307,048 | £170,149 | £116,963 |
| Net Assets | £399,219 | £367,623 | £330,738 | £269,220 | £191,437 |
| Shareholder Funds | £330,738 | £269,220 | £191,437 |
Filings
Recent filings only. See the full history on Companies House
| Date | Description | Made Up To | Pages | |
|---|---|---|---|---|
| 28 July 2026 | Confirmation statement with updates | 28 July 2026 | ||
| 15 July 2026 | Statement of capital following an allotment of shares | |||
| 27 February 2026 | Total exemption full accounts | 31 May 2025 | ||
| 10 November 2025 | Confirmation statement with no updates | 28 September 2025 | ||
| 24 December 2024 | Total exemption full accounts | 31 May 2024 |
Some other companies at this address
Other companies in this industry
Cambridge
London
Harrow
Oxford
Borehamwood
Need accounts figures, ownership or websites for thousands of companies? Bulk data & API →